Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin
- PMID: 29948831
- DOI: 10.1007/s11739-018-1886-y
Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin
Comment on
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
